![Virginie Carmignac](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Virginie Carmignac
Plus aucun poste en cours
Health Technology
Profil
Virginie Carmignac is the founder of Termino C 2436 AB, founded in 2011.
Dr. Carmignac is the founder of Merozyne Therapeutics AB, founded in 2018.
Anciens postes connus de Virginie Carmignac
| Sociétés | Poste | Fin |
|---|---|---|
Merozyne Therapeutics AB
 Merozyne Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drugs for muscular dystrophy | Fondateur | - |
Termino C 2436 AB
 Termino C 2436 AB Pharmaceuticals: MajorHealth Technology Develops therapy treatment for children with muscular disorder | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Termino C 2436 AB
Termino C 2436 AB Pharmaceuticals: MajorHealth Technology Develops therapy treatment for children with muscular disorder | Health Technology |
Merozyne Therapeutics AB
Merozyne Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drugs for muscular dystrophy | Health Technology |
